Regulation of RelB expression during the initiation of dendritic cell differentiation

Molecular and Cellular Biology

Volumn 25, Issue 17, 2005, Pages 7900-7916

  Cejas, Pedro J ^a   Carlson, Louise M ^a   Kolonias, Despina ^a   Zhang, Jian ^a   Lindner, Inna ^a   Billadeau, Daniel D ^b   Boise, Lawrence H ^a   Lee, Kelvin P ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE C; PROTEIN KINASE C BETA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELB;

ARTICLE; CELL DIFFERENTIATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENDRITIC CELL; ENHANCER REGION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MONOCYTE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; RNA STABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; GENE EXPRESSION REGULATION; HUMANS; PROMOTER REGIONS (GENETICS); PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS; RNA STABILITY; RNA, SMALL INTERFERING; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTOR RELB; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 23844451425     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.17.7900-7916.2005     Document Type: Article

References (64)

1. Ackerman, A. L., and P. Cresswell. 2003. Regulation of MHC class I transport in human dendritic cells and the dendritic-like cell line KG-1. J. Immunol. 170:4178-4188.
2. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767-811.
3. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
4. Boehmelt, G., J. Madruga, P. Dorfler, K. Briegel, H. Schwarz, P. J. Enrietto, and M. Zenke. 1995. Dendritic cell progenitor is transformed by a conditional v-Rel estrogen receptor fusion protein v-RelER. Cell 80:341-352.
5. Bren, G. D., N. J. Solan, H. Miyoshi, K. N. Pennington, L. J. Pobst, and C. V. Paya. 2001. Transcription of the RelB gene is regulated by NF-κB. Oncogene 20:7722-7733.
6. Carrasco, D., R. P. Ryseck, and R. Bravo. 1993. Expression of relB transcripts during iymphoid organ development: specific expression in dendritic antigen-presenting cells. Development 118:1221-1231.
7. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF + TNFα. J. Exp. Med. 184:695-706.
8. Chen, C., and A. J. Sytkowski. 2001. Erythropoietin activates two distinct signaling pathways required for the initiation and the elongation of c-myc. J. Biol. Chem. 276:38518-38526.
9. Clark, G. J., S. Gunningham, A. Troy, S. Vuckovic, and D. N. Hart. 1999. Expression of the RelB transcription factor correlates with the activation of human dendritic cells. Immunology 98:189-196.
10. Cogswell, P. C., R. I. Scheinman, and A. S. Baldwin, Jr. 1993. Promoter of the human NF-κB p50/p105 gene. Regulation by NF-κB subunits and by c-REL. J. Immunol. 150:2794-2804.
11. Corey, L. L., C. S. Weirich, I. J. Benjamin, and R. E. Kingston. 2003. Localized recruitment of a chromatin-remodeling activity by an activator in vivo drives transcriptional elongation. Genes Dev. 17:1392-1401.
12. Dallinger, G., H. Oberkofler, C. Seelos, and W. Patsch. 1999. Transcriptional elongation of the rat apolipoprotein A-I gene: identification and mapping of two arrest sites and their signals. J. Lipid Res. 40:1229-1239.
13. + hemopoietic progenitors to dendritic cells: evidence for protein kinase C-mediated signaling. J. Immunol. 160:3689-3697.
14. Dobrzanski, P., R. P. Ryseck, and R. Bravo. 1995. Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100. Oncogene 10:1003-1007.
15. Dong, X., T. Craig, N. Xing, L. A. Bachman, C. V. Paya, F. Weih, D. J. McKean, R. Kumar, and M. D. Griffin. 2003. Direct transcriptional regulation of RelB by 1α,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function. J. Biol. Chem. 278:49378-49385.
16. Francis, D. A., R. Sen, N. Rice, and T. L. Rothstein. 1998. Receptor-specific induction of NF-κB components in primary B cells. Int. Immunol. 10:285-293.
17. Geijsen, N., M. Spaargaren, J. A. Raaijmakers, J. W. Lammers, L. Koenderman, and P. J. Coffer. 1999. Association of RACK1 and PKCβ with the common beta-chain of the IL-5/IL-3/GM-CSF receptor. Oncogene 18:5126-5130.
18. Guo, S., Y. Yamaguchi, S. Schilbach, T. Wada, J. Lee, A. Goddard, D. French, H. Handa, and A. Rosenthal. 2000. A regulator of transcriptional elongation controls vertebrate neuronal development. Nature 408:366-369.
19. Hooper, W. C., R. T. Abraham, C. L. Ashendel, and G. E. Woloschak. 1989. Differential responsiveness to phorbol esters correlates with differential expression of protein kinase C in KG-1 and KG-1a human myeloid leukemia cells. Biochim. Biophys. Acta 1013:47-54.
20. + dendritic cell phenotype. Arch. Dermatol. Res. 293:147-158.
21. Ju, X. S., C. Hacker, J. Madruga, S. M. Kurz, S. Knespel, G. Blendinger, S. Rose-John, and Z. Martin. 2003. Towards determining the differentiation program of antigen-presenting dendritic cells by transcriptional profiling, Eur. J. Cell Biol 82:75-86.
22. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621-663.
23. Keegan, B. R., J. L. Feldman, D. H. Lee, D. S. Koos, R. K. Ho, D. Y. Stainier, and D. Yelon. 2002. The elongation factors Pandora/Spt6 and Foggy/Spt5 promote transcription in the zebrafish embryo. Development 129:1623-1632.
24. Keene, R. G., A. Mueller, R. Landick, and L. London. 1999. Transcriptional pause, arrest and termination sites for RNA polymerase II in mammalian N- and c-myc genes. Nucleic Acids Res. 27:3173-3182.
25. Kistler, B., A. Relink, R. Marienfeld, M. Neumann, and T. Wirth. 1998. Induction of nuclear factor-κB during primary B cell differentiation. J. Immunol. 160:2308-2317.
26. Koeffler, H. P., R. Billing, A. J. Lusis, R. Sparkes, and D. W. Golde. 1980. An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood 56:265-273.
27. Krumm, A., T. Meulia, M. Brunvand, and M. Groudine. 1992. The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region. Genes Dev. 6:2201-2213.
28. Lernbecher, T., B. Kistler, and T. Wirth. 1994. Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells. EMBO J. 13:4060-4069.
29. Li, J., M. L. Mbow, L. Sun, L. Li, G. Yang, D. E. Griswold, A. Schantz, D. J. Shealy, T. J. Goletz, J. Wan, and D. Peritt. 2004. Induction of dendritic cell maturation by IL-18. Cell. Immunol. 227:103-108.
30. Lin, L., G. N. DeMartino, and W. C. Greene. 1998. Cotranslational biogenesis of NF-κB p50 by the 26S proteasome. Cell 92:819-828.
31. Linial, M., and M. Groudine. 1985. Transcription of three c-myc exons is enhanced in chicken bursal lymphoma cell lines. Proc. Natl. Acad. Sci. USA 82:53-57.
32. Linial, M., N. Gunderson, and M. Groudine. 1985. Enhanced transcription of c-myc in bursal lymphoma cells requires continuous protein synthesis. Science 230:1126-1132.
33. Lin-Lee, Y. C., S. M. Soyal, A. Surguchov, S. Sanders, W. Strobl, and W. Patsch. 1995. Thyroid hormone influences conditional transcript elongation of the apolipoprotein A-I gene in rat liver. J. Lipid Res. 36:1586-1594.
34. Liptay, S., R. M. Schmid, E. G. Nabel, and G. J. Nabel. 1994. Transcriptional regulation of NF-κB2: evidence for κB-mediated positive and negative autoregulation. Mol. Cell. Biol. 14:7695-7703.
35. Lombardi, L., P. Ciana, C. Cappellini, D. Trecca, L. Guerrini, A. Migliazza, A. T. Maiolo, and A. Neri. 1995. Structural and functional characterization of the promoter regions of the NFκB2 gene. Nucleic Acids Res. 23:2328-2336.
36. Martin, E., B. O'Sullivan, P. Low, and R. Thomas. 2003. Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity 18:155-167.
37. Mrozek, K., S. M. Tanner, K. Heinonen, and C. D. Bloomfield. 2003. Molecular cytogenetic characterization of the KG-1 and KG-1a acute myeloid leukemia cell lines by use of spectral karyotyping and fluorescence in situ hybridization. Genes Chromosomes Cancer 38:249-252.
38. Muto, A., J. Ruland, L. M. McAllister-Lucas, P. C. Lucas, S. Yamaoka, F. F. Chen, A. Lin, T. W. Mak, G. Nunez, and N. Inohara. 2002. Protein kinase C-associated kinase (PKK) mediates Bel10-independent NF-κB activation induced by phorbol ester. J. Biol. Chem. 277:31871-31876.
39. Neumann, M., H. Fries, C. Scheicher, P. Keikavoussi, A. Kolb-Maurer, E. Brocker, E. Serfling, and E. Kampgen. 2000. Differential expression of Rel/ NF-κB and octamer factors is a hallmark of the generation and maturation of dendritic cells. Blood 95:277-285.
40. O'Sullivan, B. J., K. P. MacDonald, A. R. Pettit, and R. Thomas. 2000 RelB nuclear translocation regulates B cell MHC molecule, CD40 expression, and antigen-presenting cell function. Proc. Natl. Acad. Sci. USA 97:11421-11426.
41. Ouaaz, F., J. Arron, Y. Zheng, Y. Choi, and A. A. Beg. 2002. Dendritic cell development and survival require distinct NF-κB subunits. Immunity 16: 257-270.
42. Perkel, J. M., M. C. Simon, and A. Rao. 2002. Identification of a c-myb attenuator-binding factor. Leuk. Res. 26:179-190.
43. Pettit, A. R., K. P. MacDonald, B. O'Sullivan, and R. Thomas. 2000. Differentiated dendritic cells expressing nuclear RelB are predominantly located in rheumatoid synovial tissue perivascular mononuclear cell aggregates. Arthritis Rheum. 43:791-800.
44. Platzer, B., A. Jorgl, S. Taschner, B. Hocher, and H. Strobl. 2004. RelB regulates human dendritic cell subset development by promoting monocyte intermediates. Blood 104:3655-3663.
45. Rossi, F., M. McNagny, G. Smith, J. Frampton, and T. Graf. 1996. Lineage commitment of transformed haematopoietic progenitors is determined by the level of PKC activity. EMBO J. 15:1894-1901.
46. Ryseck, R. P., P. Bull, M. Takamiya, V. Bours, U. Siebeulist, P. Dobrzanski, and R. Bravo. 1992. RelB, a new Rel family transcription activator that can interact with p50-NF-κB. Mol. Cell. Biol. 12:674-684.
47. Saijo, K., I. Mecklenbrauker, A. Santana, M. Leitger, C. Schmedt, and A. Tarakhovsky. 2002. Protein kinase C beta controls nuclear factor κB activation in B cells through selective regulation of the IκB kinase alpha. J. Exp. Med. 195:1647-1652.
48. Shortman, K., and Y. J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:151-161.
49. Soilleux, E. J., R. Barten, and J. Trowsdale. 2000. DC-SIGN; a related gene, DC-SIGNR: and CD23 form a cluster on 19p13. J. Immunol. 165:2937-2942.
50. Solan, N. J., H. Miyoshi, E. M. Carmona, G. D. Bren, and C. V. Paya. 2002. RelB cellular regulation and transcriptional activity are regulated by p100. J. Biol. Chem. 277:1405-1418.
51. Speirs, K., L. Lieberman, J. Caamano, C. A. Hunter, and P. Scott. 2004. Cutting edge: NF-κB2 is a negative regulator of dendritic cell function. J. Immunol. 172:752-756.
52. + progenitor to dendritic cell differentiation from a human cell line model. J. Immunol. 162:3237-3248.
53. Suciu-Foca Cortesini, N., F. Piazza, E. Ho, R. Ciubotariu, J. LeMaoult, R. Dalla-Favera, and R. Cortesini. 2001. Distinct mRNA microarray profiles of tolerogenic dendritic cells. Hum. Immunol. 62:1065-1072.
54. Suhasini, M., and R. B. Pilz. 1999. Transcriptional elongation of c-myb is regulated by NF-κB (p50/RelB). Oncogene 18:7360-7369.
55. Suhasini, M., C. D. Reddy, E. P. Reddy, J. A. DiDonato, and R. B. Pilz. 1997. cAMP-induced NF-κB (p50/relB) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation. Oncogene 15:1859-1870.
56. Ueberla, K., Y. Lu, E. Chung, and W. A. Haseltine. 1993. The NF-κB p65 promoter. J. Acquir. Immune Defic. Syndr. 6:227-230.
57. Valero, R., M. L. Baron, S. Guerin, S. Beliard, H. Lelouard, B. Kahn-Perles, B. Vialettes, C. Nguyen, J. Imbert, and P. Naquet. 2002. A defective NF-κB/RelB pathway in autoimmune-prone New Zealand black mice is associated with inefficient expansion of thymocyte and dendritic cells. J. Immunol. 169:185-192.
58. Weih, D. S., Z. B. Yilmaz, and F. Weih. 2001. Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J. Immunol. 167:1909-1919.
59. Weih, F., G. Warr, H. Yang, and R. Bravo. 1997. Multifocal defects in immune responses in RelB-deficient mice. J. Immunol. 158:5211-5218.
60. Wilson, H. L., and H. C. O'Neill. 2003. Identification of differentially expressed genes representing dendritic cell precursors and their progeny. Blood 102:1661-1669.
61. + dendritic cells. Immunity 9:839-847.
62. Xiao, G., E. W. Harhaj, and S. C. Sun. 2001. NF-κB-inducing kinase regulates the processing of NF-κB2 p100. Mol. Cell 7:401-409.
63. Yamamoto, Y., and R. B. Gaynor. 2004. IκB kinases: key regulators of the NF-κB pathway. Trends Biochem. Sci. 29:72-79.
64. Yoshimura, S., J. Bondeson, B. M. Foxwell, F. M. Brennan, and M. Feldmann. 2001. Effective antigen presentation by dendritic cells is NF-κB dependent: coordinate regulation of MHC, costimulatory molecules and cytokines. Int. Immunol. 13:675-683.